Two Sigma Investments
NVNO

Two Sigma Investments’s enVVeno Medical NVNO Stock Holding History

Two Sigma Investments’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,561
Closed -$51.2K – 4818
2025
Q4 		$51.2K Buy
+4,561
New +$88.6K ﹤0.01% 3935
2022
Q2 		– Sell
-953
Closed -$213K – 2809
2022
Q1 		$213K Sell
953
-970
-50% -$188K ﹤0.01% 2323
2021
Q4 		$444K Buy
+1,923
New +$542K ﹤0.01% 3366

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's NVNO Position: Q1 2026 in Review

Two Sigma Investments sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 4,561 shares — an estimated $51.2K sold.

Two Sigma Investments first reported a position in NVNO in Q4 2021 and held it in 3 quarters. The position peaked at $444K in Q4 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Two Sigma Investments reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 4,561 enVVeno Medical shares in Q1 2026, an estimated $51.2K.
  • Two Sigma Investments first reported a position in enVVeno Medical in Q4 2021 and held it in 3 quarters.
  • Two Sigma Investments's enVVeno Medical position peaked at $444K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.